首页> 外文期刊>Journal of psychiatry & neuroscience: JPN >5-HT1A receptor, 5-HT2A receptor and serotonin transporter binding in the human auditory cortex in depression
【24h】

5-HT1A receptor, 5-HT2A receptor and serotonin transporter binding in the human auditory cortex in depression

机译:5-HT1A受体,5-HT2A受体和血清素转运蛋白在抑郁症的人体听觉皮层中结合

获取原文
获取原文并翻译 | 示例
           

摘要

Background: Serotonergic system abnormalities are implicated in many psychiatric disorders, including major depression. The temporal lobe receives a high density of serotonergic afferent projections, and responses in the primary auditory cortex to sound are modulated by serotonergic tone. However, the associations between changes in serotonergic tone, disease state and changes in auditory cortical function remain to be clarified. Methods: We quantified serotonin 1A (5-HT1A) receptor binding, serotonin 2A (5-HT2A) receptor binding, and serotonin transporter (SERT) binding in Brodmann areas (BA) 41/42, 22, 9 and 4 from postmortem brain sections of 40 psychiatrically healthy controls and 39 individuals who had a history of a major depressive episode (MDE). Results: There was 33% lower 5-HT2A receptor binding in BA 41/42 in individuals who had an MDE than in controls (p = 0.0069). Neither 5-HT1A nor SERT binding in BA 41/42 differed between individuals who had an MDE and controls. We also found 14% higher 5-HT1A receptor binding (p = 0.045) and 21% lower SERT binding in BA 9 of individuals who had an MDE (p = 0.045). Limitations: The study was limited by the small number of postmortem brain samples including BA 41/42 available for binding assays and the large overlap between suicide and depression in the MDE sample. Conclusion: Depression may be associated with altered serotonergic function in the auditory cortex involving the 5-HT2A receptor and is part of a wider view of the pathophysiology of mood disorders extending beyond psychopathology.
机译:背景:血清奈良症系统异常涉及许多精神病疾病,包括重大抑郁症。颞叶接收高密度的血清奈良患者传入突出物,并且通过Serotonergic调制对声音皮层的反应进行调节。然而,仍然澄清了血清奈奈语,疾病状态和听觉皮质功能变化之间的变化之间的关联。方法:我们量化血清癌地区(Ba)41/42,22,22,22,22,22,22,22,22,22,9和4中的血清酮1a(5-ht1a)受体结合,血清素2a(5-ht2a)受体结合,血清素转运蛋白转运蛋白(sert)结合在40个精神上健康的控制和39名有一个主要抑郁情节(MDE)的人。结果:在具有MDE的个体中,在BA 41/42中有33%的5-HT2A受体结合而不是对照组(p = 0.0069)。在BA 41/42中既不是5-HT1A也不是SERT结合在有MDE和控制的个体之间不同。我们还发现14%的5-HT1A受体结合(p = 0.045)和21%的患有MDE的子项中的子项中的SERT结合(P = 0.045)。局限性:该研究受到少量后期脑样本的限制,包括用于结合测定的BA 41/42,并且在MDE样品中的自杀与抑郁症之间的大重叠。结论:抑郁症可能与涉及5-HT2A受体的听觉皮质中的改变的血清奈莫肽功能有关,并且是延伸超出精神病理学的情绪障碍病理生理学的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号